Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Immune profiles in primary squamous cell carcinoma of the head and neck.
Journal: Oral oncology
Published: November 19, 2018
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy.
Journal: Nature communications
Published: June 23, 2017
In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia.
Journal: Cell death discovery
Published: January 30, 2017
SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 03, 2016
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma.
Journal: Oral oncology
Published: October 25, 2014
The relative expression of Mig6 and EGFR is associated with resistance to EGFR kinase inhibitors.
Journal: PloS one
Published: November 26, 2012
Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy.
Journal: Molecular cancer therapeutics
Published: August 29, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026